Synthesis of anticancer medicine Raltiprexed

A synthetic process, a drug mine technology, applied in the field of new synthetic process of the anticancer drug raltitrexed, which can solve the problems of long reaction time and high price, and achieve the effect of long reaction time

Inactive Publication Date: 2004-04-07
CAPITAL NORMAL UNIVERSITY
View PDF0 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In this synthetic route, the introduction of the methyl group on the N atom needs to use sodium hydride as a strong basic catalyst, and the reaction must be carried out under strict anhydrous conditions, and the reaction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis of anticancer medicine Raltiprexed
  • Synthesis of anticancer medicine Raltiprexed
  • Synthesis of anticancer medicine Raltiprexed

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] The synthetic route is as follows:

[0023]

[0024] The first step: the synthesis of N-(5-carboxy-2-thiophenoyl)-L-diethyl glutamate (I):

[0025] Suspend 2.93 g (17.2 mmol) of 2,5-thiophenedicarboxylic acid in 30 mL of dry tetrahydrofuran (THF), and add N, N'-dicyclohexylcarbodiimide (DCC) 3.55 g (17.2 mmol). After stirring for a while, 3.5 g (17.2 mmol) of L-diethyl glutamate dissolved in 20 mL of dry THF was added dropwise, and the reaction was stirred overnight at room temperature. Filter, wash the filter cake with THF, combine the filtrate and washings, and remove THF by rotary evaporation. The residue was dissolved in 15 mL of chloroform, then petroleum ether was added until cloudy, and after standing at room temperature, the precipitated solid was removed by filtration. The filtrate was rotary evaporated to remove the solvent to obtain 3.67 g of viscous liquid with a yield of 59.8%.

[0026] The second step: the synthesis of N-[5-[N-(tert-butoxycarbonyl)a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The synthesis of anticancer medicine Raltitrexed with 2, 5-thienyl diformic acid and diethyl glutamate as initial material and through six reaction steps of monocondensation, rearrangement, N-methylation, e;limination of tert-butoxy carbonyl group, condensation with 6-bromomethyl-2-methyl-4-quinbolone and saponification. The present invention has total yield of 18.1%, higher than that of available synthesis line, less reaction steps, mild condition and simple operation, and is suitable for mass production.

Description

technical field [0001] The invention belongs to a process for chemically synthesizing medicines, in particular to a new process for synthesizing anticancer drug Raltitrexed. Background technique [0002] Raltitrexed is a quinazoline antifolate that produces antitumor effects by specifically inhibiting thymidylate synthase (TS), an enzyme that converts deoxyuridine monophosphate (dUMP) into It is converted into deoxythymidine monophosphate (dTMP), which is one of the key enzymes in the process of DNA biosynthesis. Raltitrexed is quickly metabolized into multiple forms of polyglutamic acid in the cell and exerts a stronger enzyme inhibitory effect than the parent drug. In the treatment of colorectal cancer, its efficacy is better than or similar to that of 5-fluorouracil Combining with folinic acid, but avoiding the toxic and side effects of 5-fluorouracil and complicated administration methods, it has become the first-line drug for the treatment of advanced colorectal cancer...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61P35/00C07D409/12
Inventor 曹胜利
Owner CAPITAL NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap